U3 Pharma GmbH
10Patents
10Active
10Granted
48Portfolio score
Filing activity: Jan 3, 2007 → Aug 21, 2019 · 7 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7705130B2 | Antibodies directed to HER-3 and uses thereof | Chemistry; Metallurgy | 40 | Active |
| US8771695B2 | Antibodies directed to HER-3 and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US9101760B2 | Material and methods for treating or preventing HER-3 associated diseases | Chemistry; Metallurgy | 6 | Active |
| US8933202B2 | AXL antibodies | Chemistry; Metallurgy | 6 | Active |
| US8841424B2 | Humanized AXL antibodies | Chemistry; Metallurgy | 5 | Active |
| US9249230B2 | Antibodies directed to HER-3 and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11840736B2 | Nucleic acid biomarker and use thereof | Physics | 0 | Active |
| US9284379B2 | FGFR4 antibodies | Chemistry; Metallurgy | 0 | Active |
| US8828382B2 | Heparin-binding epidermal growth factor-like growth factor binding proteins | Chemistry; Metallurgy | 0 | Active |
| US8394927B2 | FGFR4 antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.